Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients

Transplantation

Volumn 81, Issue 3, 2006, Pages 350-354

  Takada, Yasutsugu ^a   Haga, Hironori ^a   Ito, Takashi ^a   Nabeshima, Motoshige ^a   Ogawa, Kohei ^a   Kasahara, Mureo ^a   Oike, Fumitaka ^a   Ueda, Mikiko ^a   Egawa, Hiroto ^a   Tanaka, Koichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Hepatitis C virus; Living donor; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 32844463876     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000197554.16093.d1     Document Type: Article

References (31)

1. Gane E. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transplant 2003; 9: S28-S34.
2. Prieto M, Berenguer M, Rayon J, et al. High incidence of allograft cirrhosis in HCV genotype 1b following transplantation. Hepatology 1999; 29: 250-256.
3. Feray C, Caccamo L, Alexander G, et al. HCV and liver transplantation: Preliminary results of a European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology 1999; 117: 619-625.
4. Sanchez-Fueyo A, Restrepo J, Quinto L, et al. Impact of recurrence of HCV infection after liver transplantation on the long-term viability of the graft. Transplantation 2002; 73: 56-63.
5. Berenguer M, Prieto M, Juan FS, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202-210.
6. Forman L, Lewis J. Association between hepatitis C infection and survival after 31orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896.
7. Velidedeoglu E, Mange KC, Frank A, et al. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV-recipients. Transplantation 2004; 77: 1834-1842.
8. Gaglio PJ, Malireddy S, Russo RS, et al. Hepatitis C recurrence in recipients of grafts from living vs cadaveric liver donors [abstract]. Hepatology 2002; 36: 265A.
9. Ghobrial RM, Amersi F, Farmer DG, et al. Rapid and severe early HCV recurrence following adult living donor liver transplantation [abstract]. Am J Transplant 2002; 2: 163A.
10. Gaglio PJ, Malireddy S, RusLevitt BS, et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003; 9: 1028-1035.
11. Garcia-Retortillo M, Forns X, Llovet JM, et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004; 40: 699-707.
12. Everson GT, Trotter J. Role of adult living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003; 9: S64-S68.
13. Russo MW, Galanko J, Beavers K, et al. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004; 10: 340-346.
14. Bozorgzadeh A, Jain A, Ryan C, et al. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation 2004; 77: 1066-1070.
15. Shiffman ML, Stravitz RT, Contos MJ, et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004; 10: 1248-1255.
16. Sugawara Y, Makuuchi M. Should living donor liver transplantation be offered to patients with hepatitis C virus cirrhosis? J Hepatol 2005; 42: 472-475.
17. Ohno T, Mizokami M, Wu RR, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35; 201-207.
18. Inomata Y, Uemoto S, Asonuma K, et al. Right lobe graft in living donor liver transplantation. Transplantation 2000; 69: 258-264.
19. Kasahara M, Takada Y, Fujimoto Y, et al. Impact of with middle hepatic vein graft in right lobe living donor liver transplantation. Am J Transpl 2005; 5: 1339-1346.
20. Inomata Y, Tanaka K, Egawa H, et al. The evolution of immunosupression with FK506 in pediatric living related liver transplantation. Transplantation 1996; 61: 247-252.
21. Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002; 73: 1959-1961.
22. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-663.
23. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-293.
24. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
25. Berenguer M, Prieto M, Cordoba J, et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol 1998; 28: 756-763.
26. Wiesner RH, Rakela J, Ishitani MB, et al. Recent advances in liver transplantation. Mayo Clin Proc 2003; 78: 197-210.
27. Berenguer M. What determines the natural history of recurrent hepatitis C after liver transplantation. J Hepatol 2005; 42: 448-479.
28. Humar A, Horn K, Kalis A, et al. Living donor and split-liver transplants in hepatitis C recipients: Does liver regeneration increase the risk for recurrence? Am J Transplant 2005; 5: 399-405.
29. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815-820.
30. Shuhart MC, Bronner MP, Gretch DR, et al. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 1997; 26: 1646-1652.
31. Russo MW, Shrestha R. Is severe recurrent hepatitis C more common after adult living donor liver transplantation? Hepatology 2004; 40: 5245-5246.